KZR
Kezar Life Sciences Inc
NASDAQ: KZR · HEALTHCARE · BIOTECHNOLOGY
$7.31
+0.14% today
Updated 2026-04-30
Market cap
$53.59M
P/E ratio
—
P/S ratio
6.03x
EPS (TTM)
$-7.66
Dividend yield
—
52W range
$4 – $8
Volume
0.1M
Kezar Life Sciences Inc (KZR) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Total assets | $11.42M | $54.22M | $114.68M | $89.51M | $151.84M | $217.93M | $299.57M | $221.24M | $144.68M |
| Cash & equivalents | $9.75M | $51.03M | $24.18M | $14.95M | $21.23M | $62.88M | $40.46M | $35.49M | $41.75M |
| Current assets | $10.49M | $52.33M | $109.81M | $81.13M | $144.81M | $211.65M | $285.72M | $206.95M | $137.49M |
| Total liabilities | $28.85M | $79.91M | $5.88M | $11.47M | $10.86M | $21.06M | $29.70M | $33.66M | $27.77M |
| Current liabilities | $651000.00 | $1.48M | $3.34M | $6.00M | $6.44M | $8.21M | $11.00M | $17.74M | $20.33M |
| Long-term debt | — | — | — | — | — | $9.62M | $9.83M | $10.07M | $5.11M |
| Shareholder equity | $-17.43M | $-25.69M | $108.80M | $78.05M | $140.98M | $196.88M | $269.87M | $187.57M | $116.92M |
| Retained earnings | $-17.51M | $-26.03M | $-49.20M | $-84.28M | $-126.02M | $-180.65M | $-248.89M | $-350.76M | $-434.50M |
| Accounts receivable | $377000.00 | $498000.00 | $5000.00 | $642000.00 | $766000.00 | $70000.00 | — | $2.29M | $424000.00 |
| Inventory | — | — | — | $1.24M | $1.97M | $2.50M | — | — | — |
| Goodwill | — | — | — | — | — | — | — | — | — |